Red Light Holland Corp. (CSE:TRIP)
Canada · Delayed Price · Currency is CAD 0.0300
-0.0050 (-14.29%)
Jun 30, 2026, 2:13 PM EST
Red Light Holland Revenue
Red Light Holland had revenue of 1.26M CAD in the quarter ending December 31, 2025, with 8.25% growth. This brings the company's revenue in the last twelve months to 4.17M, down -22.37% year-over-year. In the fiscal year ending March 31, 2025, Red Light Holland had annual revenue of 4.94M with 4.05% growth.
Revenue (ttm)
4.17M
Revenue Growth
-22.37%
P/S Ratio
4.42
Revenue / Employee
40.09K
Employees
104
Market Cap
18.42M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 4.94M | 192.40K | 4.05% |
| Mar 31, 2024 | 4.75M | 802.31K | 20.31% |
| Mar 31, 2023 | 3.95M | 1.62M | 69.84% |
| Mar 31, 2022 | 2.33M | 2.21M | 1,995.96% |
| Mar 31, 2021 | 110.96K | - | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ayr Wellness | 650.97M |
| iAnthus Capital Holdings | 193.99M |
| Rubicon Organics | 60.76M |
| MediPharm Labs | 43.28M |
| Medicure | 31.32M |
| Avicanna | 25.83M |
| Greenway Greenhouse Cannabis | 9.13M |
| PharmaCielo | 1.75M |
Red Light Holland News
- 12 days ago - Red Light Holland Reports Positive Preclinical Study Results for Coca in Weight Gain Prevention Post GLP-1 from Magdalena Biosciences, the Joint Venture Held Through Its Wholly Owned Subsidiary, Filament Health - Newsfile Corp
- 22 days ago - Red Light Holland's Wholly Owned Subsidiary, Filament Health, Signs Agreement to Supply PEX010 Botanical Psilocybin Drug Candidate for Study at GHU Paris Psychiatrie & Neurosciences in France - Newsfile Corp
- 26 days ago - Red Light Holland Announces Filament Health's PEX010 Drug Candidate, the Standardized and Patented Natural Psilocybin Trusted Across 80+ Studies Globally, Selected by UCSF for Study Probing Preclinical Alzheimer's Markers - Newsfile Corp
- 5 weeks ago - Red Light Holland Expands New Zealand Partnership with Allu Therapeutics to Advance Access to Filament Health's GMP-Compliant PEX010 Botanical Psilocybin Drug Candidate - Newsfile Corp
- 6 weeks ago - Red Light Holland's Wholly Owned Subsidiary, Filament Health, Advances PEX010 Clinical Footprint with New Canadian Academic Studies in Palliative Care, Bipolar II Depression, and Healthy Adult Mechanism Research - Newsfile Corp
- 6 weeks ago - Red Light Holland Announces Shareholder Approval of Name Change and Announces Voting Results from 2026 Annual General and Special Meeting of Shareholders - Newsfile Corp
- 7 weeks ago - Red Light Holland's Wholly Owned Subsidiary, Filament Health, Expands Distribution of PEX010 Across Canadian and U.S. Research Institutions - Newsfile Corp
- 2 months ago - Red Light Holland Announces Intention to Rebrand - Newsfile Corp